Pfizer Ltd. Company Cash Flow Statement & Analysis

(Rs in Cr.)	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Profit Before Tax	1,016.09	746.07	824.01	772.89	668.72
Net CashFlow-Operating Activity	659.75	256.84	355.68	667.08	427.33
Net Cash Used In Investing Activity	-71.34	53.70	-36.05	-575.02	-468.84
NetCash Used in Fin. Activity	-205.34	-235.14	-345.79	-180.51	-1,571.07
Net Inc/Dec In Cash And Equivlnt	383.07	75.40	-26.16	-88.45	-1,612.58
Cash And Equivalnt Begin of Year	112	36.60	62.76	151.21	1,763.79
Cash And Equivalnt End Of Year	495.07	112	36.60	62.76	151.21

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article